IVA
Inventiva S.A.
There isn't enough reported data to score IVA yet.
IVA Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
IVA's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
IVA PE Valuation
IVA has no meaningful PE right now: it lost money over the past year.
IVA Forward outlook
There aren't enough analyst estimates for IVA to show an outlook.
IVA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2025 | -$4.18 | -$1.89 |
| Q4 2024 | -$3.42 | -$0.72 |
IVA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $1.4M | -71% |
| Q4 2025 | $32K | -100% |
| Q2 2025 | $4.9M | +10763% |
| Q4 2024 | $10.2M | -41% |
| Q2 2024 | $45.5K | -98% |
| Q4 2023 | $17.3M | +1% |
| Q2 2023 | $2.1M | +2737% |
| Q4 2022 | $17.1M | +280% |
IVA's revenue is recovering but still below its 2023 peak: $1M last quarter, up 3083% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -5394% | +122043 points |
| Q4 2025 | -257580% | -257274 points |
| Q2 2025 | -1413% | +1480 points |
| Q4 2024 | -495% | -342 points |
| Q2 2024 | -127437% | -72928 points |
| Q4 2023 | -306% | +451 points |
| Q2 2023 | -2893% | +18128 points |
| Q4 2022 | -153% | +7295 points |
IVA's operating margin was −5394% last quarter, up 122043 points from the same quarter a year ago.
IVA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2022 | -$21.1M | +$10.3M |
| Q2 2022 | -$29.5M | -$16M |
| Q4 2021 | -$31.3M | -$5M |
| Q2 2021 | -$13.5M | -$9.5M |
| Q4 2020 | -$26.3M | -$15.5M |
| Q2 2020 | -$4M | +$16.9M |
| Q4 2019 | -$10.8M | +$10.4M |
| Q2 2019 | -$20.9M | -$3.6M |
IVA has burned cash in almost every quarter: −$177M over the past year, against −$75M the year before.
IVA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +109% | +56.9M shares |
| 1 year | +159% | +66.8M shares |
| 3 years | +390% | +86.6M shares |
| 5 years | +985% | +98.8M shares |
IVA has 109M diluted shares, up 159% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | $56.6M |
| Q4 2025 | — |
| Q4 2022 | — |
| Q2 2022 | — |
| Q4 2021 | — |
| Q2 2021 | — |
| Q4 2020 | — |
| Q2 2020 | — |
IVA Net Leverage
IVA's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
IVA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.5 | Neutral |
| Stochastic | 42.0 | Neutral |
IVA's weekly RSI is 47 (neutral) and its Stochastic is 42 (neutral).
IVA PE vs Healthcare Sector
IVA has no meaningful PE right now: it lost money over the past year.
IVA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.51 | 11% above |
| 20 week MA | $4.06 | 4.4% below |
| 50 week MA | $4.78 | 19% below |
| 100 week MA | $4.22 | 8.1% below |
| 200 week MA | $3.89 | 0.3% below |
IVA has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 0.3% below its 200-week average.
IVA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $13.4 | $12.8 | -4.6% |
| 2021 | $12.8 | $13.7 | +7.1% |
| 2022 | $13.7 | $4.45 | -68% |
| 2023 | $4.45 | $4.52 | +1.6% |
| 2024 | $4.52 | $2.20 | -51% |
| 2025 | $2.20 | $4.48 | +104% |
| 2026 YTD | $4.48 | $3.88 | -13% |
IVA's yearly returns have swung widely, from +104% in 2025 to −68% in 2022. It's down 13% so far in 2026.